APA (7th ed.) Citation

Wang, L., Zhou, S., Zhou, Y., & Lu, J. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Wiley.

Chicago Style (17th ed.) Citation

Wang, Li, Shao-quan Zhou, Yu Zhou, and Jia-xi Lu. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Wiley.

MLA (9th ed.) Citation

Wang, Li, et al. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Wiley.